Document is current

Article History

Accepted: 11 December 2023

First Online: 20 January 2024

Declarations

:

: Funding provided by Novartis Pharmaceuticals Corporation.

: Patient-level data for 'Data on file' in this manuscript are not available for sharing as there is a reasonable likelihood that individual patients could be re-identified. All other data have been published previously as cited, and are therefore included in the respective main manuscripts. Further information can be requested from the authors of the individual included studies.

: All authors are employees of Novartis.

: Medical writing support under the direction of the authors was provided by Isabella Kaufmann of Novartis Pharmaceuticals UK Ltd, according to Good Publication Practice guidelines.

: Not applicable.

: All authors contributed to the selection and interpretation of data, were involved in the drafting and critically reviewing of the manuscript, provided final approval of the version to be published, and agree to be accountable for all aspects of the work.

: Not applicable.